- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07719816
Qualitative Study of Student Financial Insecurity and Psychiatry (QUALIPEPSY)
A Qualitative Exploration of the Impact of Financial Insecurity on the Development of Psychiatric Disorders and the Use of Healthcare Services Among Students
Since the COVID-19 pandemic, mental health disorders have increased significantly, particularly among young people. In France, the proportion of young people aged 18 to 25 suffering from depression almost doubled between 2017 and 2021. This phenomenon particularly affects students, who are already identified as being at greater risk of mental health disorders than the general population. Medical students seem to be particularly vulnerable: in 2021, a national study showed very high rates of depression and suicidal thoughts in this population. The main factor associated with depression was the feeling of financial hardship.
Students often face multiple forms of insecurity. Financially, they have limited resources and struggle to cover their basic needs such as housing, food and healthcare. Socially, many experience significant isolation, particularly when they are away from their families or under pressure from their studies. All of this has a significant impact on their mental health. Unfortunately, many students do not seek help due to lack of time, resources, or awareness of support services. The 2021 study showed that only one-third of medical students suffering from depression received appropriate treatment.
The aim of the study is to explore the lived experiences of the students concerned in order to identify what they perceive as the various aspects of student precarity (housing, transport, isolation, financial difficulties, etc.) and the links they perceive between these and their psychological distress. This study will deepen our understanding of these factors by exploring students' lived experiences, and will bring to light elements not identified by quantitative studies.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Marie Benhammani-Godard
- Telefonnummer: 0033158411190
- E-post: marie.godard@aphp.fr
Studer Kontakt Backup
- Navn: Cédric LEMOGNE, MC, PhD
- Telefonnummer: 0033 1 42 34 85 76
- E-post: cedric.lemogne@aphp.fr
Studiesteder
-
-
IDF
-
Paris, IDF, Frankrike, 75014
- Adult Psychiatry Department - Hôtel-Dieu Hospital
-
Ta kontakt med:
- Cédric LEMOGNE, MD, PhD
- Telefonnummer: 0033 1 42 34 85 76
- E-post: cedric.lemogne@aphp.fr
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- A student enrolled at Paris Sciences et Lettres (PSL) University or the Faculty of Health Sciences at Université Paris Cité (UPC),
- Aged 18 or over,
- Fluent in French,
- be a student,
- have used the PPOP scheme,
- not object to participating after receiving clear information.
Exclusion Criteria:
- Participants under the age of 18,
- not enrolled at PSL universities or the UPCS Faculty of Health Sciences,
- insufficient proficiency in French to conduct an interview,
- refusal to participate,
- clinical vulnerability deemed incompatible by the referring consultant.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Patients
Students
|
Semistrukturerte intervjuer
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Semi-structured interview
Tidsramme: Day of inclusion
|
This is an exploratory, inductive qualitative study.
The aim is not to measure but to explore and understand these students' lived experiences, without any preconceived assumptions
|
Day of inclusion
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Semi-structured interview
Tidsramme: Day of inclusion
|
This is an exploratory, inductive qualitative study.
The aim is not to measure but to explore and understand these students' lived experiences, without any preconceived assumptions
|
Day of inclusion
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Studiestol: Ariel FRAJERMAN, MD, Institut National de la Santé Et de la Recherche Médicale, France
- Studieleder: Jordan SIBEONI, MD, PhD, Institut National de la Santé Et de la Recherche Médicale, France
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- APHP260752 - QUALIPEPSY
- 2026-A01287-44 (Annen identifikator: France : Ministry of Health)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .